The Food and Drug Administration, Centers for Disease Control and Prevention and Centers for Medicare & Medicaid Services today launched the Tri-Agency Task Force for Emergency Diagnostics, which will work to rapidly develop and deploy diagnostic tests to clinical and public laboratories in an emergency. “Timely implementation of [emergency use authorization] diagnostic assays in the U.S. health care system is dependent upon laboratories understanding the instructions for use and applying them to the patient samples received for testing,” said Kate Goodrich, CMS chief medical officer and director of the Center for Clinical Standards and Quality. “As part of this task force, it is our goal to provide clear and consistent guidance to laboratories on the application of [Clinical Laboratory Improvement Amendments] requirements for these emergency assays.”

AHA Cyber Intel
While we may feel inundated with alarming news about escalating cyber threats against healthcare organizations, there is also some good news. Let’s explore how…
Headline
Two new AHA briefs outline field-tested strategies on strengthening supply chain resilience and hospital capacity readiness to maintain quality of care during…
Perspective
Public
Twenty-five years ago, our nation experienced one of the darkest days in its history. The terrorist attacks of Sept. 11, 2001, took thousands of innocent lives…
Headline
The Federal Office of Rural Health Policy’s Rural Health Redesign Center will host a webinar on Sept. 24 at 2 p.m. ET, where hospital CEOs will discuss the…
Headline
The AHA’s Association for the Health Care Environment will host a webinar Sept. 8 at 2 p.m. ET that will discuss strategies environmental services leaders can…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…